ecteinascidin 743 has been researched along with Sensitivity and Specificity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esser, M; Fritz, J; Horger, M; Kloth, C; Kopp, HG; Reinert, CP; Thaiss, WM | 1 |
| Beijnen, JH; López-Lázaro, L; Rosing, H; Stokvis, E | 1 |
| D'Incalci, M; Damia, G; Erba, E; Garbi, A; Simone, M; Tavecchio, M | 1 |
| Blanco-Aparicio, C; Carnero, A; Cigudosa, JC; Fominaya, J; Jimeno, J; Leal, JF; Moneo, V; Piris, MA; Romero, L; Sánchez-Beato, M; Serelde, BG; Tercero, JC | 1 |
| Beijnen, JH; Bult, A; Cameron, L; Faircloth, G; Floriano, P; Gómez, A; Henrar, RE; Hillebrand, MJ; Jimeno, JM; Rosing, H; Vermorken, JB | 1 |
| Bertino, JR; Cordon-Cardo, C; Elisseyeff, Y; Faircloth, G; Jhanwar, S; Jimeno, J; Li, WW; Takahashi, N | 1 |
1 review(s) available for ecteinascidin 743 and Sensitivity and Specificity
| Article | Year |
|---|---|
New drugs from the sea.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Depsipeptides; Dioxoles; Humans; Isoquinolines; Marine Biology; Peptides, Cyclic; Pharmaceutical Preparations; Sensitivity and Specificity; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2004 |
5 other study(ies) available for ecteinascidin 743 and Sensitivity and Specificity
| Article | Year |
|---|---|
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents, Alkylating; Female; Humans; Male; Middle Aged; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Trabectedin | 2018 |
Simple and sensitive liquid chromatographic quantitative analysis of the novel marine anticancer drug Yondelis (ET-743, trabectedin) in human plasma using column switching and tandem mass spectrometric detection.
Topics: Antineoplastic Agents, Alkylating; Calibration; Chromatography, Liquid; Clinical Trials, Phase II as Topic; Dioxoles; Humans; Isoquinolines; Mass Spectrometry; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin | 2004 |
Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53.
Topics: Cell Proliferation; Dioxoles; Doxorubicin; Humans; Karyotyping; Mutation; RNA, Small Interfering; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2007 |
Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dioxoles; Evaluation Studies as Topic; Humans; Isoquinolines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tetrahydroisoquinolines; Trabectedin; Urochordata | 1998 |
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Cycle; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Inhibitory Concentration 50; Isoquinolines; Methotrexate; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |